Sleep, recovery, and performance: the new frontier in high-performance athletics.

Sleep, recovery, and performance: the new frontier in high-performance athletics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Sleep, recovery, and performance: the new frontier in high-performance athletics. Abstract Text:

Charles Samuels,

The relationship of sleep to post-exercise recovery (PER) and athletic performance is a topic of great interest because of the growing body of scientific evidence confirming a link between critical sleep factors, cognitive processes, and metabolic function. Sleep restriction (sleep deprivation), sleep disturbance (poor sleep quality), and circadian rhythm disturbance (jet lag) are the key sleep factors that affect the overall restorative quality of the sleep state. This article discusses these theoretic concepts, presents relevant clinical cases, and reviews pilot data exploring the prevalence of sleep disturbance in two groups of high-performance athletes.

Sleep, recovery, and performance: the new frontier in high-performance athletics. Publishing Authors By Initials

C Samuels,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Sleep, recovery, and performance: the new frontier in high-performance athletics. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neurologic clinics

VOLUME: 26

Page Numbers: 169-80

Journal Abbreviation:

ISSN: 0733-8619

DAY: 25

MONTH: Feb

YEAR: 2008

Sleep, recovery, and performance: the new frontier in high-performance athletics. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8219232

Sleep, recovery, and performance: the new frontier in high-performance athletics. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Sleep, recovery, and performance: the new frontier in high-performance athletics. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Sleep, recovery, and performance: the new frontier in high-performance athletics.

AFFILIATION: Centre for Sleep and Human Performance, #106, 51 Sunpark Drive SE, Calgary, Alberta, Canada T2X 3V4; Department of Family Medicine, Faculty of Medicine, University of Calgary Health Sciences Centre, 3330 Hospital Drive NW, Calgary, Canada AB T2N 4N1.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neurol Clin

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Sleep, recovery, and performance: the new frontier in high-performance athletics Related Publications

• Artificial regulation of ospC expression in Borrelia burgdorferi.
• California surveillance for pesticide-related illness and injury: coverage, bias, and limitations.
• Cancer chemotherapeutic response and intravenous hyperalimentaion.
• Characterization of Arabidopsis ABCG11/WBC11, an ATP binding cassette (ABC) transporter that is required for cuticular lipid secretion.
• Clinical trial of bleomycin (NSC-125066) in the treatment of metastatic renal carcinoma.
• Clozapine use in a forensic population in a New South Wales prison hospital.
• Combination vincristine (NSC-67574) and hydroxyurea (NSC-32065) for metastatic renal carcinoma.
• Early effects of testosterone propionate on the seminal vesicles of castrate rats.
• Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors.
• Genetics of cholesterol and lipoprotein metabolism.
• Gill Samuels.
• History of safe use as applied to the safety assessment of novel foods and foods derived from genetically modified organisms.
• Industrial accidents and peripheral vascular diseases.
• Influence of previous diet on metabolism during fasting.
• Intrathecal methotrexate (NSC-740) therapy for brain tumors in children.
• Meeting the health needs of rural America--the Kirksville mission.
• Mitochondrial AZT metabolism.
• Necrosis of intraocular tissues.
• Nuclear receptor coregulator (NRC): mapping of the dimerization domain, activation of p53 and STAT-2, and identification of the activation domain AD2 necessary for nuclear receptor signaling.
• PARTICIPATION OF THE OCULAR APPENDAGES IN SYMPATHETIC OPHTHALMIA AND ITS BEARING ON ENUCLEATION.
• Psychiatrists' ascertained treatment needs for mental disorders in a population-based sample.
• Role of PSF-TFE3 oncoprotein in the development of papillary renal cell carcinomas.
• SPECTROFLUORIMETRIC MEASUREMENT OF 1,3-DIAMINO-5-METHYLPHENAZINIUM CHLORIDE (NSC-33419) IN URINE.
• Selection against Pathogenic mtDNA Mutations in a Stem Cell Population Leads to the Loss of the 3243A-->G Mutation in Blood.
• Sleep, recovery, and performance: the new frontier in high-performance athletics.
• Temperature-induced regulation of RpoS by a small RNA in Borrelia burgdorferi.
• The application of post-market monitoring to novel foods.
• The effects of promazine on psychiatric symptoms.
• Thiopropazate hydrochloride (dartal) chemotherapy for emotional disorders; a clinical evaluation.
• Varieties of dual-process theory for probabilistic reasoning.